Furthermore, a significant up‐regulation of Fn14 protein was observed in tissue sections taken from patients with ALD and NASH, which revealed the co‐expression of Fn14 with α‐SMA+ myofibroblasts in the fibrotic scar. The gene discussed is TNFRSF12A; the disease is metabolic dysfunction-associated steatohepatitis.